26th Jan 2010 07:00
|
For Immediate Release |
26 January 2010 |
Genus plc
Notification of Interim Results
for the six months ended 31 December 2009
Genus, a world leading animal genetics company, will announce its interim results for the six months ended 31 December 2009 on Thursday, 25 February 2010.
A briefing for analysts will be held at 10:00am on 25 February 2010 at Buchanan Communication, 45 Moorfields, London EC2Y 9AE.
For further information please contact:
Buchanan Communications Tel: 020 7466 5000
Charles Ryland
Suzanne Brocks
Jennie Spivey
About Genus
Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors.
Genus' worldwide sales are made in seventy countries under the trade marks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality, and use these to supply the global dairy and meat supply chain.
The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global production and distribution network.
Headquartered in Basingstoke, England, Genus companies operate in 30 countries on six continents, with research laboratories located in Madison, Wisconsin, USA.
Related Shares:
Genus